Prostate Cancer

« Treatment »

Genetic Testing for Advanced Prostate Cancer Can Help Tailor Treatment

Dr. Eli Van Allen Dana-Farber Cancer Institute

Doctors are now considering testing the inherited genetics of all men with advanced prostate cancer, ideally at diagnosis, in order to understand their disease better. Not only will it provide clues as to how to treat the cancer, says Dr. Eli Van Allen, a medical oncologist at Dana-Farber Cancer Institute, but it may also reveal the cancer’s genetic tendency to behave in a certain way, which is a vital predictor for how to treat.

In addition, learning whether you have a genetic cancer gene will be extremely significant for other family members, since men with a family history are considered high risk and need to be screened at a much younger age.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Eli Van Allen is a medical oncologist specializing in prostate, bladder, kidney and testicular cancers at Dana-Farber Cancer Institute. Read More

Treatment: Watching and Waiting

Active surveillance for prostate cancer is a very specific protocol with requirements and guidelines. While this is not ideal for everyone, it may work for certain patients and spare them the side effects of treatment.


What is Active Surveillance?


The Benefits of Active Surveillance

Dr. James Brooks
Stanford Medicine

When Is Active Surveillance Not Enough?

Dr. David Wise
NYU Perlmutter Cancer Center